Standard Operating Procedure for Selection of Bio-Adhesive Polymers in Gel Manufacturing
| Department | Gel Manufacturing |
|---|---|
| SOP No. | SOP/GM/167/2025 |
| Supersedes | SOP/GM/167/2022 |
| Page No. | Page 1 of 10 |
| Issue Date | 09/06/2025 |
| Effective Date | 11/06/2025 |
| Review Date | 09/06/2027 |
1. Purpose
To describe the procedure for evaluating, screening, and selecting suitable bio-adhesive polymers during the formulation development of gel products for enhanced mucosal and dermal adhesion.
2. Scope
This SOP is applicable to R&D and formulation scientists involved in the development of gel-based drug delivery systems that require bio-adhesion, such as topical, vaginal, rectal, ophthalmic, and buccal gels.
3. Responsibilities
- Formulation Scientist: Responsible for identifying, screening, and documenting the selection of bio-adhesive polymers.
- R&D Manager: To review and approve the selected polymers based on experimental results.
- QA Representative: To verify
documentation and ensure compliance with regulatory expectations.
4. Accountability
Head – Gel Manufacturing and Head – Quality Assurance are accountable for ensuring implementation and compliance with this SOP.
5. Procedure
5.1 Polymer Pre-Selection Criteria
- Compile a list of pharmaceutically acceptable bio-adhesive polymers from pharmacopeial and GRAS sources.
- Ensure the selected polymers meet regulatory acceptability for the intended route of administration.
- Consider compatibility with APIs, solvents, preservatives, and other formulation components.
5.2 Evaluation Parameters
- Evaluate candidate polymers based on the following properties:
- Bio-adhesive strength (using texture analyzer or modified balance method)
- Swelling index
- Viscosity behavior
- Mucoadhesive time or retention time
- Chemical compatibility with API and excipients
- Effect on drug release rate
- Perform adhesion studies on relevant biological substrates (e.g., mucosa, skin tissue).
5.3 Laboratory Trials
- Prepare experimental gel formulations incorporating different concentrations of each polymer (typically 0.5% to 5% w/w).
- Evaluate preliminary formulations for physical appearance, stability, spreadability, and adhesiveness.
- Shortlist the most promising polymers based on performance results.
5.4 Final Selection and Documentation
- Document results of all trials and evaluations in the Polymer Screening Log (Annexure-1).
- Summarize analytical and physical performance data in the Polymer Evaluation Summary (Annexure-2).
- Select the most suitable polymer for the final formulation and record justification in the Final Selection Report (Annexure-3).
5.5 Regulatory and Safety Considerations
- Ensure polymer specifications align with pharmacopoeial standards (IP/USP/Ph. Eur.).
- Refer to safety data sheets and toxicological databases for human usage data.
- Avoid polymers with known allergens or sensitizers for dermal or mucosal use.
6. Abbreviations
- API: Active Pharmaceutical Ingredient
- GRAS: Generally Recognized As Safe
- QA: Quality Assurance
- IP: Indian Pharmacopoeia
- USP: United States Pharmacopeia
- Ph. Eur.: European Pharmacopoeia
7. Documents
- Polymer Screening Log – Annexure-1
- Polymer Evaluation Summary – Annexure-2
- Final Selection Report – Annexure-3
8. References
- ICH Q8 – Pharmaceutical Development
- USP General Chapter <1004> – Bioadhesive Drug Delivery Systems
- WHO Technical Series on Mucosal Drug Delivery
9. SOP Version
Version: 2.0
10. Approval Section
| Prepared By | Checked By | Approved By | |
|---|---|---|---|
| Signature | |||
| Date | |||
| Name | |||
| Designation | Formulation Scientist | QA Executive | Head – Manufacturing |
| Department | Gel Manufacturing | Quality Assurance | Manufacturing |
11. Annexures
Annexure-1: Polymer Screening Log
| Polymer Name | Batch No. | Concentration (%) | Appearance | Initial Viscosity |
|---|---|---|---|---|
Annexure-2: Polymer Evaluation Summary
| Polymer | Bio-Adhesion Score | Stability (days) | Release Profile | Remarks |
|---|---|---|---|---|
Annexure-3: Final Selection Report
| Selected Polymer | |
|---|---|
| Concentration | |
| Justification | |
| Approved By |
Revision History
| Revision Date | Revision No. | Change Description | Reason | Approved By |
|---|---|---|---|---|
| 12/06/2022 | 1.0 | Initial version | New SOP | QA Manager |
| 09/06/2025 | 2.0 | Added annexures and evaluation criteria | Updated for R&D integration | QA Manager |